OrthoPediatrics Corp
KIDS
查看詳細走勢圖
17.340USD
-0.070-0.40%
收盤 12/26, 16:00（美東）報價延遲15分鐘
434.84M總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-0.40%
5天
+1.58%
1月
-6.72%
6月
-18.86%
今年開始到現在
-25.19%
1年
-24.25%
查看詳細走勢圖
TradingKey OrthoPediatrics Corp股票評分
單位: USD 更新時間: 2025-12-26操作建議
OrthoPediatrics Corp當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名72/207位。機構持股佔比非常高，近一個月多位分析師給出公司評級為買入。最高目標價24.14。中期看，股價處於平穩狀態。近一個月，市場表現較差，但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
OrthoPediatrics Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
7
分析師
買入
評級
24.143
目標均價
+32.43%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
OrthoPediatrics Corp亮點
亮點風險
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
業績高增長
公司營業收入穩步增長，連續3年增長67.41%
估值高估
公司最新PE估值-8.86，處於3年歷史高位
機構減倉
最新機構持股16.80M股，環比減少13.54%
PRFDX持倉
明星投資者PRFDX持倉，最新持倉1.65K股
OrthoPediatrics Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
OrthoPediatrics Corp簡介
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
公司代碼KIDS
公司OrthoPediatrics Corp
CEOBailey (David R)
網址https://www.orthopediatrics.com/
常見問題
OrthoPediatrics Corp(KIDS)的當前股價是多少？
OrthoPediatrics Corp(KIDS)的當前股價是 17.340。
OrthoPediatrics Corp 的股票代碼是什麼？
OrthoPediatrics Corp的股票代碼是KIDS。
OrthoPediatrics Corp股票的52週最高點是多少？
OrthoPediatrics Corp股票的52週最高點是27.600。
OrthoPediatrics Corp股票的52週最低點是多少？
OrthoPediatrics Corp股票的52週最低點是15.280。
OrthoPediatrics Corp的市值是多少？
OrthoPediatrics Corp的市值是434.84M。
OrthoPediatrics Corp的淨利潤是多少？
OrthoPediatrics Corp的淨利潤為-37.82M。
現在OrthoPediatrics Corp(KIDS)的股票是買入、持有還是賣出？
根據分析師評級，OrthoPediatrics Corp(KIDS)的總體評級為買入，目標價格為24.143。
OrthoPediatrics Corp(KIDS)股票的每股收益（EPS TTM）是多少
OrthoPediatrics Corp(KIDS)股票的每股收益（EPS TTM）是-1.957。
相關品種
+1.30%
+0.29%
+0.03%
+0.11%
-0.49%
-0.05%
-0.13%
-0.75%
+0.67%
+0.59%
+1.91%
+0.59%
+0.34%
+0.09%
+0.04%
+0.64%
+0.26%
+0.05%
+0.26%
+0.67%
